Global Finance News
29 Jan 2026, 22:50
Altria Group reported its fourth-quarter and full-year 2025 results and issued earnings guidance for 2026, highlighting steady earnings growth, progress in its smoke-free portfolio, and substantial cash returns to shareholders.
For full-year 2025, Altria delivered adjusted diluted EPS of $5.42, representing growth of 4.4% year over year, despite a decline in reported revenues. Net revenues totaled $23.3 billion for the year, down 3.1% from 2024, reflecting ongoing volume pressures in combustible products. Fourth-quarter adjusted diluted EPS was $1.30, while reported diluted EPS declined sharply due to special items and a higher effective tax rate.
The company returned approximately $8 billion to shareholders in 2025 through a combination of dividends and share repurchases. During the year, Altria repurchased $1 billion of its shares and paid $7.0 billion in dividends, underscoring its continued focus on shareholder returns. As of year-end, $1 billion remained available under its current share repurchase authorization.
Looking ahead, Altria guided for 2026 full-year adjusted diluted EPS in a range of $5.56 to $5.72, implying growth of 2.5% to 5.5% from the 2025 base. Management said the outlook reflects confidence in the company’s core earnings power, cost discipline, and strategic initiatives.
Strategically, Altria continued to advance its smoke-free portfolio in 2025, with FDA marketing authorizations granted for certain on! PLUS nicotine pouch products and additional applications submitted for new flavors and strengths. The company also reported progress on its Optimize & Accelerate cost-savings initiative, which remains on track to deliver at least $600 million in cumulative savings by 2029, supporting reinvestment and long-term growth objectives.
For full-year 2025, Altria delivered adjusted diluted EPS of $5.42, representing growth of 4.4% year over year, despite a decline in reported revenues. Net revenues totaled $23.3 billion for the year, down 3.1% from 2024, reflecting ongoing volume pressures in combustible products. Fourth-quarter adjusted diluted EPS was $1.30, while reported diluted EPS declined sharply due to special items and a higher effective tax rate.
The company returned approximately $8 billion to shareholders in 2025 through a combination of dividends and share repurchases. During the year, Altria repurchased $1 billion of its shares and paid $7.0 billion in dividends, underscoring its continued focus on shareholder returns. As of year-end, $1 billion remained available under its current share repurchase authorization.
Looking ahead, Altria guided for 2026 full-year adjusted diluted EPS in a range of $5.56 to $5.72, implying growth of 2.5% to 5.5% from the 2025 base. Management said the outlook reflects confidence in the company’s core earnings power, cost discipline, and strategic initiatives.
Strategically, Altria continued to advance its smoke-free portfolio in 2025, with FDA marketing authorizations granted for certain on! PLUS nicotine pouch products and additional applications submitted for new flavors and strengths. The company also reported progress on its Optimize & Accelerate cost-savings initiative, which remains on track to deliver at least $600 million in cumulative savings by 2029, supporting reinvestment and long-term growth objectives.